Rival European pharma giants Sanofi and GSK have both forged new partnerships to bolster their preclinical research. | Rival ...

Formation Bio is inking a deal worth more than $600 million in biobucks for ex-China rights to a next-gen immunology asset ...

Francis Medical is heating up with a 510 (k) clearance from the FDA for its water vapor ablation therapy aimed at cancers of ...

A Chinese biotech helmed by an AstraZeneca veteran has secured $108 million in series B funds, which the company will use to ...

Two affiliates of Apple Tree Partners have filed for bankruptcy, a move designed to continue funding the venture firm's portfolio biotechs as a funding dispute with a top investor plays out. | Two ...

Roche has lifted the lid on the data behind its second phase 3 giredestrant win, linking the oral selective estrogen receptor degrader (SERD) to a 30% reduction in the risk of invasive disease ...